MedPath

To evalutate the effect of Proniosome infused lidocaine and commercially available lidocaine gels for pain reduction during intraoral injections.

Not Applicable
Conditions
Health Condition 1: K041- Necrosis of pulp
Registration Number
CTRI/2023/02/049535
Lead Sponsor
Dr Afreen Anjum S
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Children of age group of 8-12 years.

2)Children requiring administration of buccal infiltration anesthesia irrespective of treatment.

3)Children with Franklâ??s behavior rating 3 and 4.

4)Children with good general health (ASA I).

5)Children who are willing to participate and whose parents give informed consent.

Exclusion Criteria

1)Medically compromised children.

2)Patient with history of anxiety disorder.

3)Children or parents not willing to participate.

4)Patients with history of allergy to local anesthesia.

5)Patients on medication that can alter pain perception.

6)Presence of lesion at the site of application.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare and evaluate the pain perception following topical application of proniosome infused lidocaine and commercially lidocaine gelsTimepoint: 5 minutes after application
Secondary Outcome Measures
NameTimeMethod
to evaluate for any adverse effects following topical application of comparator agentTimepoint: 5 minutes after application
© Copyright 2025. All Rights Reserved by MedPath